Tissue infiltrating lymphocytes: The role of cytokines in their growth and differentiation

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 3, 2010, Pages 239-249

  Cianci, R ^a   Pagliari, D ^a   Pietroni, V ^a   Landolfi, R ^a   Pandolfi, F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apoptosis; Cytokines; Inflammatory skin diseases; Melanoma; Primary immunodeficiency diseases; Rheumatoid arthritis; Tissue infiltrating lymphocytes; Tumor immunology

Indexed keywords

CYTOKINE;

APOPTOSIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COMMON VARIABLE IMMUNODEFICIENCY; CORONARY ARTERY DISEASE; DIGESTIVE SYSTEM CANCER; GRAFT REJECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INTESTINE FLORA; LYMPHOCYTE; MELANOMA; MICROENVIRONMENT; MUCOSAL IMMUNITY; NEOPLASM; PLASTICITY; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN INFLAMMATION; TH17 CELL; TISSUE INFILTRATING LYMPHOCYTE; ANIMAL; CYTOLOGY; DERMATITIS; INFLAMMATION; NEOPLASMS; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; DERMATITIS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; LYMPHOCYTES; NEOPLASMS;

EID: 77957906135     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Castellani ML, Toniato E, Felaco P, et al. Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells. Eur J Inflam 2009; 7:183-90.
2. Castellani ML, Felaco ME, Pandolfi F, et al. Mast cells and arachidonic acid cascade in inflammation. Eur J Inflamm 2009; 7:131-37.
3. Pandolfi F, Cianci R, Pagliari D, Landolfi R, and Cammarota G. Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm 2009; 2009:132028.
4. Pandolfi F, Cianci R, Cammarota G, et al. Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. Ann Clin Lab Sci 2010; 40:3-9.
5. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120:776-94.
6. Pandolfi F, Corte G, Quinti I, et al. Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia. Clin Exp Immunol 1983; 51:470-4.
7. Castigli E, Geha RS. TACI, isotype switching, CVID and IgAD. Immunol Res 2007; 38:102-11.
8. Borte S, Pan-Hammarstrom Q, Liu C, et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood 2009; 114:4089-98.
9. Cianci R, Cammarota G, Lolli S, Gasbarrini GB, and Pandolfi F. Abnormal synthesis of IgA in coeliac disease and related disorders. J Biol Regul Homeost Agents 2008; 22:99-104.
10. Giambra V, Cianci R, Lolli S, et al. Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol 2009; 183:8280-5.
11. Mannon PJ, Fuss IJ, Dill S, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology 2006; 131:748-56.
12. Del Prete G, Santi L, Andrianaivoarimanana V, et al. Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system. Int J Immunopathol Pharmacol 2009; 22:133-43.
13. Inoue K, Koike E, Yanagisawa R, et al. Pulmonary exposure to soluble cell wall beta-(1, 3)-glucan of aspergillus induces proinflammatory response in mice. Int J Immunopathol Pharmacol 2009; 22:287-97.
14. Giovannetti A, Pierdominici M, Di Iorio A, et al. Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des 2008; 14:253-68.
15. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006; 6:595-601.
16. Pandolfi F, Pierdominici M, Marziali M, et al. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol 2000; 94:153-9.
17. Pandolfi F, Oliva A, Sacco G, et al. Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS 1993; 7:323-9.
18. Scott S, Pandolfi F, Kurnick JT. Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells. J Exp Med 1990; 172:1873-6.
19. Pilling D, Akbar AN, Girdlestone J, et al. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999; 29:1041-50.
20. Di Renzo L, Gloria-Bottini F, Saccucci P, et al. Role of interleukin-15 receptor alpha polymorphisms in normal weight obese syndrome. Int J Immunopathol Pharmacol 2009; 22:105-13.
21. Pandolfi F, Cianci R, Lolli S, et al. Strategies to overcome obstacles to successful immunotherapy of melanoma. Int J Immunopathol Pharmacol 2008; 21:493-500.
22. Giannitti C, Benucci M, Caporali R, et al. Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection. Int J Immunopathol Pharmacol 2009; 22:543-6.
23. Ria F, Penitente R, De Santis M, et al. Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res Ther 2008; 10:R135.
24. Liftman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010; 140:845-58.
25. Capria A, De Nardo D, Baffetti FR, et al. Long-term anti-TNF-a treatments reverse the endothelial dysfunction in rheumatoid arthritis: the biological coherence between synovial and endothelial inflammation. Int J Immunopathol Pharmacol 2010; 23:255-62.
26. Elder JT. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 2009; 10:201-9.
27. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157:209-15.
28. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009; 183:3170-6.
29. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. Int J Immunopathol Pharmacol 2009; 22:961-6.
30. Zampetti A, Mastrofrancesco A, Flori E, et al. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-75.
31. Colombo D, Flori L, Altomare G, Aste N, Sgarbi S. Clinical outcome evaluation following cyclosporine a treatment in moderate to severe psoriasis: a retrospective study. Int J Immunopathol Pharmacol 2010; 23:363-7.
32. Campanati A, Goteri G, Simonetti O, et al. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: video capillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol 2009; 22:371-7.
33. Yang J, Chu Y, Yang X, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1472-83.
34. Kurnick JT, Ramirez-Montagut T, Boyle LA, et al. A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter. J Immunol 2001; 167:1204-11.
35. Hishii M, Kurnick JT, Ramirez-Montagut T, Pandolfi F. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. Clin Exp Immunol 1999; 116:388-94.
36. Xu X, Xing B, Hu M, et al. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy. Cytotherapy 2010; 12:190-200.
37. Oble DA, Loewe R, Yu P, Mihm MC. Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 2009; 9:3.
38. Ladanyi A, Mohos A, Somlai B, et al. FOXP3(+) Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma. Pathol Oncol Res 2010; 10.1007/s12253-010-9254-x
39. Kasper HU, Drebber U, Stippel DL, Dienes HP, and Gillessen A. Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol 2009; 15:5053-7.
40. Shen Z, Zhou S, Wang Y, et al. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 2010; 10.1007/s00432-010- 0816-9
41. Chew V, Tow C, Teo M, et al. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol 2010; 52:370-9.
42. Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25:2586-93.
43. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112:362-73.
44. Cianci R, Iacopini F, Petruzziello L, Cammarota G, Pandolfi F, Costamagna G. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009; 44:108-15.
45. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr Opin Cell Biol 2000; 12:563-8.
46. Targan SR, Feagan BG, Fedorak RN, et al. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology 2007; 132:1672-83.
47. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
48. Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009; 31:209-19.
49. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76-83.
50. CatellaniML, Felaco P, Pandolfi F. et al. Inflammatory compounds: neuropeptide substance P and cytokines. Eur J Inflam 2009; 7: 63-69,
51. Abbate A, Bussani R, Liuzzo G, et al. Sudenn coronary death, fatal acute myocardial infartcion and widespread coronary and myocardial inflammation. Heart 2008: 94:737-742.